Concepedia

Eduardo Arellano‐Rodrigo

EA

Statistics

Publications

37

Citations

2.6K

H-Index

26

Active since

2002

Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(Current)

Hospital Clínic de Barcelona

Universitat de Barcelona

Hospital Del Mar

Hospital Clínico Universitario de Valencia

Eduardo Arellano‐Rodrigo is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, hematology, and thrombosis.

ORCID

Top concepts

Publications per year

2002–2023

37

Publications

37

Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.

Eduardo Arellano‐Rodrigo, Alberto Álvarez‐Larrán, Joan Carles Reverter et al. · PubMed · 2006 · 275 citations

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

Alberto Álvarez‐Larrán, Francisco Cervantes, Arturo Pereira et al. · Blood · 2010 · 229 citations · Full text

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Álvarez‐Larrán, Arturo Pereira, Francisco Cervantes et al. · Blood · 2011 · 221 citations · Full text

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients

Alejandra Martínez‐Trillos, Anna Gayà, Margherita Maffioli et al. · Annals of Hematology · 2010 · 146 citations · Full text

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli et al. · Haematologica · 2016 · 145 citations · Full text

Rows per page

1–5 of 37